Researchers from the National Institutes of Health (NIH) have developed an artificial intelligence (AI) algorithm to help ...

Clinical Quality Language (CQL) is an HL7 specification for the expression of clinical knowledge that can be used within both the Clinical Decision Support (CDS) and Clinical Quality Measurement (CQM) ...

They're writing notes. When it comes to pain, things like how pain is affecting your daily life, your ability to work, your ability to do things with your family — lot of that gets put into ...

ClinicalWorks®, the largest ambulatory cloud EHR, today announced that North Texas Preferred Health Partners (NTPHP) is successfully utilizing Sunoh.ai, saving 50% of time spent on documentation daily ...

Yaron Werber has given his Buy rating due to a combination of factors, primarily the promising progress and outcomes of IO Biotech’s clinical trials. The company’s Phase 3 melanoma study is on ...

Klaus Tschira Institute for Integrative Computational Cardiology, Heidelberg, Germany Department of Computational Linguistics, Heidelberg University, Heidelberg, Germany Department of Internal ...

presented to its investors. Acrivon Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing precision oncology medicines using its proprietary Acrivon ...

The company's CEO, James Dentzer, expressed optimism about the progress of Curis's clinical programs and the potential of emavusertib, particularly given the durable responses observed in salvage ...

Background: With widespread scientific misinformation, access to primary literature, such as randomized clinical trials (RCTs), can empower patients in their decision-making about their health.

Tyra Bioscience, Inc ( (TYRA)) has released its Q3 earnings. Here is a breakdown of the information Tyra Bioscience, Inc presented to its investors. Tyra Biosciences, Inc. is a clinical-stage ...

Progress Notes: One Year in the Future of Medicine by Abraham Nussbaum, Postbac ’99, follows a group of medical students who train by following patients instead of physicians. Accompanying them to ...

The company reported a strong cash position, which is expected to fund operations into late 2026, and emphasized the progress made in its clinical programs, including the completion of enrollment ...